Latest News

November 10, 2020

GlycoCheck Named in Top 10 Diabetes Testing Devices for 2020

GlycoCheck has been named one of the Top 10 Diabetes Care Solution Providers in 2020 by MedTech Outlook.
June 14, 2021

Presentation at Anti-Aging Summit

We invite you to watch a FREE presentation from GlycoCheck CEO Bob Long and Chief Science Officer and GlycoCheck inventor Dr. Hans Vink. They will present […]
April 14, 2021

The NOSTRADAMUS Study: Microvascular Dysfunction in Sepsis

A new study using GlycoCheck, and co-authored by GlycoCheck Chief Science Offer, Dr. Hans Vink, reports new findings of research on patients with sepsis.
December 31, 2020

2021 Prediction: Micro Gets Tinier

Our prediction: the world of healthcare will be looking for big solutions that tackle huge problems with tiny blood vessels as the medical community begins to understand more and more that “micro” is getting even smaller.
October 28, 2020

Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study

The MYSTIC study has fueled the hypothesis that COVID-19 is actually a vascular illness and that systemic leakiness and impairment of the endothelial glycocalyx might play a central role in the development of acute respiratory distress syndrome (ARDS) and multi-organ failure.
July 14, 2020

The Glycocalyx as a “Physiological Organ”

Today we have an emerging science based on MICROvascular science and the recent discovery of what I call a "physiological organ": the Endothelial Glycocalyx or Glycocalyx for short, which evidence shows regulates many blood vascular functions and whose degradation might result in many different conditions with this common root cause.
May 19, 2020

Uncoupling of Microvascular Blood Flow and Capillary Density in Vascular Cognitive Impairment

New peer-reviewed research, using GlycoCheck, reveals the rest of the story about why blood flow and capillary density are so important to brain health.
May 12, 2020

Are Underlying Conditions Linked to COVID-19 Mortality Rates as a Result of Poor Glycocalyx Health?

Discovery Breakthrough Opportunities Underlying chronic conditions can be deadly for people with COVID-19. Answers are needed now. So it’s vital to find solutions quickly, and we’d […]
May 12, 2020

News from the Crucial Project

A new 6-million-euro project will investigate a possible common cause of heart disease and dementia using GlycoCheck. READ MORE: